Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004

Theresa L Lamagni1, Shona Neal, Catherine Keshishian

  • 1Health Protection Agency, London, United Kingdom. theresa.lamagni@hpa.org.uk

Insights

Severe Streptococcus pyogenes infections are more common than previously thought, with skin infections most frequent. Early death is a risk, highlighting the need for targeted interventions against this bacterial pathogen.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Streptococcus pyogenes (group A Streptococcus) can cause severe invasive disease.
  • Europe-wide surveillance initiatives aim to understand current epidemiologic patterns.
  • Previous estimates of severe S. pyogenes infection incidence may be underestimates.

Purpose of the Study:

  • To conduct enhanced population-based surveillance for severe S. pyogenes infections in the United Kingdom.
  • To determine the incidence, clinical manifestations, and risk factors for severe S. pyogenes disease.
  • To identify predictors of poor patient outcomes, including mortality and streptococcal toxic shock syndrome.

Main Methods:

  • Enhanced, population-based surveillance for severe S. pyogenes infections in the UK from 2003-2004.
  • Case ascertainment and data collection on demographics, clinical presentation, risk factors, and outcomes.
  • Statistical analysis to determine incidence, common manifestations, risk factors, and mortality rates.

Main Results:

  • 3,775 confirmed cases of severe S. pyogenes infection identified over 2 years (incidence 3.33/100,000 population).
  • Skin/soft tissue infections (42%) and respiratory tract infections (17%) were most common.
  • Injection drug use was a risk factor in 20% of cases; 1 in 5 patients died within 7 days.
  • Necrotizing fasciitis had a high mortality rate (34%).
  • NSAIDs, alcoholism, young age, and emm/M3 types were associated with increased risk for streptococcal toxic shock syndrome.

Conclusions:

  • Severe S. pyogenes infections pose a significant public health burden in the UK, with higher incidence than previously estimated.
  • Understanding disease patterns and risk factors is crucial for developing effective interventions.
  • Identifying predictors of poor outcomes, such as rapid mortality and toxic shock syndrome, can guide clinical management and public health strategies.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.